122 related articles for article (PubMed ID: 12088062)
1. Cytisine derivatives as high affinity nAChR ligands: synthesis and comparative molecular field analysis.
Nicolotti O; Canu Boido C; Sparatore F; Carotti A
Farmaco; 2002 Jun; 57(6):469-78. PubMed ID: 12088062
[TBL] [Abstract][Full Text] [Related]
2. 3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.
Gohlke H; Schwarz S; Gündisch D; Tilotta MC; Weber A; Wegge T; Seitz G
J Med Chem; 2003 May; 46(11):2031-48. PubMed ID: 12747776
[TBL] [Abstract][Full Text] [Related]
3. Identification of 9-fluoro substituted (-)-cytisine derivatives as ligands with high affinity for nicotinic receptors.
Houllier N; Gopisetti J; Lestage P; Lasne MC; Rouden J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6667-70. PubMed ID: 20880707
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
[TBL] [Abstract][Full Text] [Related]
5. Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities.
Boido CC; Tasso B; Boido V; Sparatore F
Farmaco; 2003 Mar; 58(3):265-77. PubMed ID: 12620422
[TBL] [Abstract][Full Text] [Related]
6. Application of [125I] (S)-5-iodonicotine, a new radioiodinated ligand, in the assay of nicotinic acetylcholine receptor binding in the brain.
Saji H; Watanabe A; Kiyono Y; Magata Y; Iida Y; Takaishi Y; Yokoyama A
Biol Pharm Bull; 1995 Nov; 18(11):1463-6. PubMed ID: 8593459
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.
Imming P; Klaperski P; Stubbs MT; Seitz G; Gündisch D
Eur J Med Chem; 2001 Apr; 36(4):375-88. PubMed ID: 11461763
[TBL] [Abstract][Full Text] [Related]
8. New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling.
Audouze K; Nielsen EØ; Olsen GM; Ahring P; Jørgensen TD; Peters D; Liljefors T; Balle T
J Med Chem; 2006 Jun; 49(11):3159-71. PubMed ID: 16722635
[TBL] [Abstract][Full Text] [Related]
9. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
10. Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis.
Nielsen SF; Nielsen EO; Olsen GM; Liljefors T; Peters D
J Med Chem; 2000 Jun; 43(11):2217-26. PubMed ID: 10841800
[TBL] [Abstract][Full Text] [Related]
11. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
Sihver W; Gillberg PG; Nordberg A
Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
[TBL] [Abstract][Full Text] [Related]
12. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza LA; Dhawan S; Kellar KJ
Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
[TBL] [Abstract][Full Text] [Related]
13. 7-Azaindole derivatives as potential partial nicotinic agonists.
Stoit AR; den Hartog AP; Mons H; van Schaik S; Barkhuijsen N; Stroomer C; Coolen HK; Reinders JH; Adolfs TJ; van der Neut M; Keizer H; Kruse CG
Bioorg Med Chem Lett; 2008 Jan; 18(1):188-93. PubMed ID: 18006307
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
[TBL] [Abstract][Full Text] [Related]
15. Characterization of [3H]cytisine binding to human brain membrane preparations.
Hall M; Zerbe L; Leonard S; Freedman R
Brain Res; 1993 Jan; 600(1):127-33. PubMed ID: 8422580
[TBL] [Abstract][Full Text] [Related]
16. The thermodynamic profile and molecular interactions of a C(9)-cytisine derivative-binding acetylcholine-binding protein from Aplysia californica.
Davis S; Rego Campello H; Gallagher T; Hunter WN
Acta Crystallogr F Struct Biol Commun; 2020 Feb; 76(Pt 2):74-80. PubMed ID: 32039888
[TBL] [Abstract][Full Text] [Related]
17. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
Carbonnelle E; Sparatore F; Canu-Boido C; Salvagno C; Baldani-Guerra B; Terstappen G; Zwart R; Vijverberg H; Clementi F; Gotti C
Eur J Pharmacol; 2003 Jun; 471(2):85-96. PubMed ID: 12818695
[TBL] [Abstract][Full Text] [Related]
18. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
Chellappan SK; Xiao Y; Tueckmantel W; Kellar KJ; Kozikowski AP
J Med Chem; 2006 May; 49(9):2673-6. PubMed ID: 16640326
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
Anderson DJ; Arneric SP
Eur J Pharmacol; 1994 Mar; 253(3):261-7. PubMed ID: 8200419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]